Not just leukemia: CMV may protect against lymphoma recurrence after allogeneic transplant

被引：2
|
作者：
Peled, Jonathan U. [1 ]
Jenq, Robert R. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Adult Bone Marrow Transplantat Serv, 1275 York Ave, New York, NY 10021 USA
来源：
LEUKEMIA & LYMPHOMA | 2017年 / 58卷 / 04期
基金：
美国国家卫生研究院;
关键词：
ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC-CELL TRANSPLANTATION; RELAPSE RISK EVIDENCE; NON-HODGKIN-LYMPHOMA; CYTOMEGALOVIRUS-INFECTION; T-CELLS; NK CELLS; ALLO-SCT; REACTIVATION; DONOR;
D O I：
10.1080/10428194.2016.1239265
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：759 / 761
页数：3
相关论文
共 50 条
  • [21] Nerve Decompression After Diabetic Foot Ulceration May Protect Against Recurrence A 3-Year Controlled, Prospective Analysis
    Nickerson, D. Scott
    Rader, Andrew J.
    JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2014, 104 (01) : 66 - 70
  • [22] CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients
    Chavaz, Lara
    Royston, Lena
    Masouridi-Levrat, Stavroula
    Mamez, Anne-Claire
    Giannotti, Federica
    Morin, Sarah
    Van Delden, Christian
    Chalandon, Yves
    Neofytos, Dionysios
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (04):
  • [23] Cidofovir as pre-emptive therapy of cytomegalovirus (CMV) infection after allogeneic transplant.
    Tagliaferri, E
    Soligo, D
    Deliliers, DL
    Della Volpe, A
    Annaloro, C
    Cardone, R
    Deliliers, GL
    BONE MARROW TRANSPLANTATION, 1999, 23 : S67 - S67
  • [24] CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia
    Akahoshi, Yu
    Nakasone, Hideki
    Takenaka, Katsuto
    Yamasaki, Satoshi
    Nakamura, Momoko
    Doki, Noriko
    Tanaka, Masatsugu
    Ozawa, Yukiyasu
    Uchida, Naoyuki
    Ara, Takahide
    Nakamae, Hirohisa
    Ota, Shuichi
    Onizuka, Makoto
    Yano, Shingo
    Tanaka, Junji
    Fukuda, Takahiro
    Kanda, Yoshinobu
    Atsuta, Yoshiko
    Kako, Shinichi
    Yanada, Masamitsu
    Arai, Yasuyuki
    BLOOD ADVANCES, 2023, 7 (12) : 2699 - 2708
  • [25] Protein Losing Enteropathy - Clinical Resolution Post Heart Transplant and Recurrence after CMV Enteritis
    Worme, M. D.
    Scolari, F.
    Kozuszko, S.
    Alonso-Gonzalez, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S483 - S483
  • [26] Cidofovir Treatment may benefit patients with low CMV-specific CD8 T cell levels after initial CMV reactivation post allogeneic stem cell transplant
    Lewis, D. J.
    Farina, F.
    Moss, P.
    Nagra, S.
    Raeiszadeh, M.
    Chen, F.
    Malladi, R.
    Craddock, C.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S196 - S196
  • [27] Efficacy of the allogeneic stem cell transplant against cutaneous T-cell lymphoma
    Postorino, M.
    Cantonetti, M.
    Cerretti, R.
    Cudillo, L.
    Picardi, A.
    Franceschini, L.
    De Angelis, G.
    Baliva, G.
    Faccia, S.
    Renzi, D.
    Rizzo, M.
    Arcese, W.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S146 - S146
  • [28] CMV reactivation may protect against relapse in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation
    Clausen, J.
    Kircher, B.
    Auberger, J.
    Schumacher, P.
    Grabmer, C.
    Muehlbacher, A.
    Gastl, G.
    Nachbaur, D.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S275 - S275
  • [29] Allogeneic Transplant for HTLV-1 Adult T-Cell Lymphoma-Leukemia
    Wang, Trent P.
    Jimenez, Antonio M.
    Lekakis, Lazaros J.
    Pereira, Denise
    Goodman, Mark
    Ramos, Juan Carlos
    Komanduri, Krishna V.
    Beitinjaneh, Amer
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S342 - S343
  • [30] Large Granular Lymphocytic Leukemia after Allogeneic Hematopoietic Stem Cell Transplant
    Wang, W.
    Bergman, S.
    Hurd, D.
    Zamkoff, K.
    Beaty, M.
    MODERN PATHOLOGY, 2014, 27 : 384A - 384A
12345